Cyto-Zyme
Natural health product licensed in Canada
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80111677
- Status
- Active licence
- Licence date
- 27 July 2021
- Revision date
- 26 July 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 1.56 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 375 FCC LU | Not calculated |
| Trigonella foenum-graecum Source : Graine | 50 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 240 mg | 60 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 18.8 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 15,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 6 mg | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 10 FCC SAPU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 16 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 8,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 8 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 2,000 FCC HUT | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 125 FCC GalU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 5 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 1.5 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 300 FCC CU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 1.25 mg | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 100 FCC ALU | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 1.2 mg | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 200 FCC SU | Not calculated |
| Diastase du malt Source : Diastase du malt | 1.11 mg | Not calculated |
| Diastase du malt Source : Diastase du malt | 200 FCC DU | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 5 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 5 FCC GU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 18.2 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 2,500 FCC DU | Not calculated |
Non-medicinal ingredients
Poudre d'Oryza Sativa (Riz), Hypromellose, NA
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80111677
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging